Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies - Wikidata - wikimedia - TriplyDB

Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies

Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies

http://www.wikidata.org/entity/Q27647874

about

Self-assembling protein nanoparticles in the design of vaccines Papillomavirus Infectious Pathways: A Comparison of Systems Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins Subunit interactions in bovine papillomavirus Structural Basis of Oligosaccharide Receptor Recognition by Human Papillomavirus The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction Capsomer vaccines protect mice from vaginal challenge with human papillomavirus Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications Papillomavirus prophylactic vaccines: established successes, new approaches.Producing recombinant adeno-associated virus in foster cells: overcoming production limitations using a baculovirus-insect cell expression strategy.Differential binding patterns to host cells associated with particles of several human alphapapillomavirus types.Nuclear import by karyopherin-βs: recognition and inhibition Characterization of virus-like particles in GARDASIL® by cryo transmission electron microscopy.Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection.Study of infectious virus production from HPV18/16 capsid chimeras.Construction of a full transcription map of human papillomavirus type 18 during productive viral infection.Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity.The choice of resin-bound ligand affects the structure and immunogenicity of column-purified human papillomavirus type 16 virus-like particles Development of a highly thermostable, adjuvanted human papillomavirus vaccine.Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins Genetic variability in L1 and L2 genes of HPV-16 and HPV-58 in Southwest China.Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation.Papillomavirus capsid proteins mutually impact structure Peptidic inhibitors for in vitro pentamer formation of human papillomavirus capsid protein l1.A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA.Naturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype.Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years.Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands.Hierarchical Order Parameters for Macromolecular Assembly Simulations I: Construction and Dynamical Properties of Order Parameters Multiscale simulation of microbe structure and dynamics.Sound efficacy of prophylactic HPV vaccination: Basics and implications.A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5 Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies.Genetic variability and phylogeny analysis of partial L1 gene of human papillomavirus variants in Buenos Aires, Argentina.Selective virus detection in complex sample matrices with photonic crystal optical cavities.Naturally Occurring Major and Minor Capsid Protein Variants of Human Papillomavirus 45 (HPV45): Differential Recognition by Cross-Neutralizing Antibodies Generated by HPV Vaccines.Rational Design of Peptide Vaccines Against Multiple Types of Human Papillomavirus.Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines.Human Papillomavirus Type16- L1 VLP Production in Insect Cells L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis.

P2860

Q26767097-84492747-DD02-4D69-97DA-2F5F6B4B6AD8 Q26801497-A5A951AA-4A64-46AE-826A-F9EF5A2D51C6 Q27013018-C65B0BAE-7AEE-4EBF-B3EE-D604CAA7AF83 Q27660305-E86A95DD-6DB0-4ABC-A82F-867CF0C68FC7 Q27666101-7F275230-50E4-4050-967C-7DD4546633E4 Q27709061-F2B41E0C-7DCD-4EB7-9F5C-BE757AE301F8 Q28743261-8EDCB9C0-66DF-4033-81EB-37A8C5D3D67F Q33469751-7A5F14CF-6D60-4A02-B682-BE5B73737EFE Q33614425-25AE799F-51B3-4F2A-A798-02B240DD9A52 Q33690975-FB4E784B-915E-466D-BACA-931F71EB268E Q33923898-1806025A-1D8F-443A-A5EA-1C860422668B Q34024485-BA542FCD-81E9-4C7F-B83F-4733F970C330 Q34033805-32F72A7B-6959-4427-A2F3-7C709F7FB049 Q34054427-1321A61A-45DC-4CF0-8D26-90603E5995E0 Q34071813-0D2E6AD0-B43D-4F20-AF9A-F7380CB4EDBE Q34193290-6976B3A9-1EA3-406E-B242-9B2F2E4F95BB Q34256293-5C273EA3-2A6E-43FA-82A9-7159150AB019 Q34259805-759483EC-E91E-4360-AC5D-984620E18B47 Q34477334-B362C2C6-2228-4A87-A2A5-0E875EF40457 Q34492140-F83EEE93-13FD-48CA-AE0E-034DEB5AD13F Q34571650-C80E6AC7-D1C5-438D-97D0-5459CAED63C6 Q34639978-BAE78B18-3D46-463C-97EC-71C110738DC5 Q34699403-F9FD0D5B-2E92-41DE-A27F-DEDC27DA156B Q35379036-310BBD95-A7DF-41ED-9781-4B753FF9858A Q35850159-5752D196-0EAF-4AAA-B8CB-5F3542ECF676 Q35861286-69BB4820-24CD-41F6-BE0B-0CED35FB190B Q35918838-FB0178C6-F53A-4877-9C32-ADD202F0F057 Q35987309-12C6CD37-3CDB-4C9F-8639-B8AF313F1847 Q35993422-B17723FE-8A97-4BC8-95A5-D33148229B39 Q36058098-8A63B02D-9962-4B7E-AABE-2081F4A1E06F Q36373404-37133C72-63D1-480D-B994-A76A1852EEEC Q36448778-27A1BD23-AD5A-4DE0-8779-1CA307ED8641 Q36540127-DF76CD6C-B0DF-4232-8B8B-D53D19A5CDD9 Q36592606-AC6C3F2B-D026-46DE-B74D-713D191F96F8 Q36681168-907065E1-E8FD-4154-B707-ABF72ECF47A0 Q36736614-24D6F115-37F9-4F40-AFB7-9CDF47BCC9CC Q36961621-B217B074-9A10-4A8D-B2C9-7EF653CF0C3A Q37162220-100B5455-DBC9-4666-B678-4C8E8DEC553D Q37205058-890A3867-0C6B-407E-9C49-C2818B702181 Q37322176-4280FFBB-EB39-440A-ACAA-A20645A5379F

P2860

Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies

http://www.wikidata.org/entity/Q27647874

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Crystal structures of four typ ...... ralizing monoclonal antibodies

@ast

Crystal structures of four typ ...... ralizing monoclonal antibodies

@en

Crystal structures of four typ ...... ralizing monoclonal antibodies

@nl

type

label

Crystal structures of four typ ...... ralizing monoclonal antibodies

@ast

Crystal structures of four typ ...... ralizing monoclonal antibodies

@en

Crystal structures of four typ ...... ralizing monoclonal antibodies

@nl

prefLabel

Crystal structures of four typ ...... ralizing monoclonal antibodies

@ast

Crystal structures of four typ ...... ralizing monoclonal antibodies

@en

Crystal structures of four typ ...... ralizing monoclonal antibodies

@nl

P1433

Q27647874-9BDD791D-0EC6-43F8-8BE1-66B8F23FAD0F

P1476

Q27647874-B7A7C7FD-5EA2-44CB-B35E-533666142F7C

P2093

Q27647874-2CC1EACC-443F-49D4-8AAA-C5C5BC4892B2

Q27647874-694689A7-3557-4ED7-B13E-BA8A6E70124C

Q27647874-9887CCE5-0F07-4460-862A-8BC8D450D0D7

Q27647874-AACC275C-7C32-4241-AFC4-A93720AC59C7

Q27647874-ACA0C9E6-F42D-4FB6-8A93-951E31691682

Q27647874-B56C2EF0-4807-4265-B170-2CCB29F7FE22

Q27647874-E2E242DC-1A65-4C8A-A277-6D72768C035C

P2860

Q27647874-05C67653-D77F-4D3D-9CA0-E03E9BA32388

Q27647874-0996DE61-6F1E-4D50-9F96-615D62BCC205

Q27647874-0B2C9D9E-54C0-496E-A601-F1C2333BC1E0

Q27647874-6BE06E78-4C7D-418B-9336-B51CB840EE9E

Q27647874-A69E3DE8-BBF0-434C-9477-B127F615F714

Q27647874-C7C11D6D-714D-4F32-8EA2-89EC44068042

Q27647874-CE88C084-F23E-410D-A85E-912F67A611C7

Q27647874-D6F6F3F7-FDC5-44E1-AD5D-7CAE1EBC7C8E

Q27647874-DE88785A-444A-450B-B81E-CE1657428CD7

Q27647874-E608CA03-0752-4BDF-95CC-101CD9DE7F0A

P304

Q27647874-D4C817E2-D8BD-4517-BF48-2AE7CC5133DD

P31

Q27647874-8B15B163-D34D-4666-BB47-2E34C25DF8E1

P3181

Q27647874-A4E61375-0676-4900-A173-FE25BF581E03

P356

Q27647874-B303ED72-DDA7-4758-971A-E4156C7FBA10

P407

Q27647874-6CB87403-44E1-4E1B-B7B7-724D7D319928

P433

Q27647874-39971DCE-0934-466B-A4D8-9C80786DB2E6

P478

Q27647874-D9C74331-13AD-417D-B581-27F3CC6C76D9

P577

Q27647874-F7176659-F346-4DDF-A7E0-C25C364F4742

P698

Q27647874-99F8E47B-DAC0-4632-A9F0-F997C620FBB0

P921

Q27647874-22C88ABC-C960-4B47-9605-ABBEEEB364B1

Q27647874-6B93272A-230F-49A6-B515-725070D2BB2C

Q27647874-D4C7FEE1-A916-403B-8CAB-8479804C1218

P3181

P356

P1433

Journal of Biological Chemistry

P1476

Crystal structures of four typ ...... ralizing monoclonal antibodies

@en

P2093

Brooke Bishop

http://www.w3.org/2001/XMLSchema#string

Jhimli Dasgupta

http://www.w3.org/2001/XMLSchema#string

Michael Klein

http://www.w3.org/2001/XMLSchema#string

Neil D Christensen

http://www.w3.org/2001/XMLSchema#string

Robert L Garcea

http://www.w3.org/2001/XMLSchema#string

Rui Zhao

http://www.w3.org/2001/XMLSchema#string

Xiaojiang S Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16

Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains

Epidemiologic classification of human papillomavirus types associated with cervical cancer

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine.

Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1.

Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops.

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.

Synthesis and assembly of infectious bovine papillomavirus particles in vitro.

Structure-based engineering of papillomavirus major capsid l1: controlling particle assembly.

P304

31803-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1123034

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M706380200

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

282

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17804402

http://www.w3.org/2001/XMLSchema#string

P921

crystal structure